Followers | 221 |
Posts | 13482 |
Boards Moderated | 7 |
Alias Born | 06/20/2022 |

Monday, March 25, 2024 8:53:50 PM
https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data
Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)
Recent STOK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 10:17:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 10:12:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 10:05:38 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/18/2025 08:56:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 08:11:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 08:08:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2025 08:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 11:05:09 AM
- Stoke Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates • Business Wire • 03/18/2025 11:00:00 AM
- Stoke Therapeutics Announces CEO Transition • Business Wire • 03/18/2025 10:58:00 AM
- Stoke Therapeutics to Present at Upcoming Investor Conferences in March • Business Wire • 02/26/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2025 09:31:47 PM
- Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments • GlobeNewswire Inc. • 02/18/2025 01:00:00 PM
- Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments • Business Wire • 02/18/2025 01:00:00 PM
- Stoke Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/08/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2025 12:06:01 PM
- Stoke Therapeutics Announces Alignment with Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen as Potentially the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome • Business Wire • 01/07/2025 12:00:00 PM
- Stoke Therapeutics to Host Webcast to Discuss Successful Global Regulatory Alignment for a Phase 3 Study of Zorevunersen as Potentially the First Disease Modifying Medicine for Dravet Syndrome • Business Wire • 01/06/2025 09:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/27/2024 10:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2024 10:13:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/23/2024 11:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2024 09:07:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2024 09:05:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2024 12:02:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2024 12:01:47 AM
FEATURED Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • Mar 20, 2025 9:00 AM
VAYK Forms Partnership with Airbnb Investing Group to Offer Service Solution • VAYK • Mar 20, 2025 9:00 AM
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger • CATV • Mar 20, 2025 8:30 AM
NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • BURU • Mar 19, 2025 8:53 AM
Authentic Holdings, Inc. to Acquire Movie and Television Library in an $11 Million Transaction • AHRO • Mar 19, 2025 8:30 AM
Wytec Begins Sales of Its Multi-State Government Contract for AI Gunshot Detection • WYTC • Mar 19, 2025 7:19 AM